Toolkits to facilitate implementation of new WHO guidelines for reducing HIV infections
At the XVIII International AIDS Conference, the Elizabeth Glaser Pediatric AIDS Foundation has issued the first phase of a series of three linked toolkits to facilitate the adaptation and implementation of the revised World Health Organization (WHO) recommendations in the following four technical areas: ARV drugs for treatment of pregnant women living with HIV and prevention of HIV infection in infants, infant and young child feeding in the context of HIV, antiretroviral therapy for HIV infection in infants and children, and antiretroviral therapy for HIV infection in adults and adolescents.
At the XVIII International AIDS Conference, the Elizabeth Glaser Pediatric AIDS Foundation has issued the first phase of a series of three linked toolkits to facilitate the adaptation and implementation of the revised World Health Organization (WHO) recommendations in the following four technical areas: ARV drugs for treatment of pregnant women living with HIV and prevention of HIV infection in infants, infant and young child feeding in the context of HIV, antiretroviral therapy for HIV infection in infants and children, and antiretroviral therapy for HIV infection in adults and adolescents.
The toolkit is organized into five steps that can be followed by technical partners to understand the revised WHO recommendations and provide technical guidance to countries in adapting the revised recommendations into national HIV guidelines and plans for their implementation. The WHO guidelines represent an important advance in reducing new HIV infections in infants, as well as improving care and treatment for children and adults living with HIV. The aim is that these toolkits will help speed the implementation of the recommendations bringing the world closer to the goal of eliminating paediatric HIV and AIDS.
Phase 1, “Understanding the Revised WHO Recommendations and Supporting Their Adaptation Into National Guidelines," will be followed soon after by Phase 2, "Planning for Program, District, and Facility-Level Implementation of the Revised WHO Guidelines," and Phase 3, "Measuring Impact and Implementation of the Revised WHO Guidelines."
